Fermenta Biotech informs about successful closure of inspection

06 Jul 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fermenta Biotech has informed that US FDA has issued an Establishment Inspection Report (EIR) for the Company’s manufacturing facility situated at Dahej, Gujarat, India with no observations as to any significant objectionable conditions, and the inspection has been successfully ‘closed’ by the US FDA.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

328.60 1.75 (0.54%)
22-Nov-2024 11:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.65
Dr. Reddys Lab 1205.10
Cipla 1479.65
Lupin 2053.05
Zydus Lifesciences 942.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.